Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03250312 · ClinicalTrials.gov registry record · NA
The Effects of OMT on the Expression Patterns of Immune Cell Biomarkers
A NA study, sponsored by A.T. Still University of Health Sciences.
- Terminated
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT03250312: Clinical Trial NA study, sponsored by A.T. Still University of Health Sciences.
NCT03250312 is a NA study that was terminated before completion, run by A.T. Still University of Health Sciences. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03250312, a NA study, was terminated before completion, sponsored by A.T. Still University of Health Sciences.
- TERMINATED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
This study intends to understand the effects of osteopathic manipulative treatment (OMT) on the expression patterns of 60 immune cell biomarkers in the peripheral blood mononuclear cells (PBMC) of each participant, before and after intervention - OMT or seated control. This study will utilize participants with a history of low back pain (LBP), and will identify and validate those immune cell biomarkers that change in most participants after OMT, by using the novel protein subcellular localization (PSL) microarray technology. This study intends to uncover the important immune cells affected by OMT techniques, therefore to uncover the molecular mechanisms of OMT.
Primary Outcome
Measure the ratio change of immune cell biomarkers in the PBMC cell of Low back pain patients after the OMT treatment
Interventions
- OTHER The Osteopathic Manipulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2017-09-13 |
| Est. Completion | 2019-08-31 |
| Phase | NA |
Why NCT03250312 stopped before completion
NCT03250312 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which The Osteopathic Manipulation is the first listed.
NCT03250312 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03250312 about?
NCT03250312 is a clinical study titled "The Effects of OMT on the Expression Patterns of Immune Cell Biomarkers". This study intends to understand the effects of osteopathic manipulative treatment (OMT) on the expression patterns of 60 immune cell biomarkers in the peripheral blood mononuclear cells (PBMC) of each participant, before and after intervention - OMT or seated control. This study will utilize partic...
What is the current status of trial NCT03250312?
This trial is currently terminated. It is a NA study. The enrollment target is 40 participants. The study started on 2017-09-13. Estimated completion is 2019-08-31.
What interventions are being tested in trial NCT03250312?
The interventions under investigation include: The Osteopathic Manipulation (OTHER).
Who is sponsoring clinical trial NCT03250312?
This trial is sponsored by A.T. Still University of Health Sciences, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03250312's enrollment target sits among peer trials
40 1447th of 2000 higher than 465 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI